Back to search

Ireland· IE-PA-EU/1/17/1224/001-002

Xermelo 250 mg film-coated tablets

A various alimentary tract and metabolism products product containing telotristat etiprate, registered in Ireland by Serb S.A.S.. The same ATC class is registered in 4 of our 19 countries.

ATC A16AX

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedXermelo 250 mg film-coated tabletsATCA16AXREGISTER NO.IE-PA-EU/1/17/1224/00…PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Telotristat etiprate is registered in 4 of 19 countries.

Countries holding a registration under ATC A16AX (various alimentary tract and metabolism products), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 3 of them publish a price we can compare per daily dose

Telotristat etiprate · ATC A16AX

4 / 19 countries

  • Finlandprice
  • Ireland
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Telotristat etiprate
Manufacturer
Serb S.A.S.
Country
Ireland (IE)
ATC code
A16AX
ATC class
Various alimentary tract and metabolism products
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/17/1224/001-002

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Telotristat etiprate in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All telotristat etiprate products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/44fbdd46-a3fb-4908-b783-8043fd04582c
GET /v1/drugs/44fbdd46-a3fb-4908-b783-8043fd04582c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "A16AX"
  ],
  "strength": null,
  "pa_number": "EU/1/17/1224/001-002",
  "substances": [
    "Telotristat etiprate"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "18/09/2017",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about telotristat etiprate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.